Covid-19: Lancet retracts paper that halted hydroxychloroquine trials
Retraction made after Guardian investigation found inconsistencies in data
Related Articles
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Our detailed breakdown of DALYs associated with a comprehensive list of pathogens on a global, regional, and country level has revealed the magnitude of the…
The continuing challenge of infectious diseases
In 2019, 2540 million (95% uncertainty interval [UI] 2290–2810) disability-adjusted life years (DALYs) were attributed to non-communicable and communicable diseases and injuries globally.1 In The…
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Substantial progress has been made in reducing LRI mortality, but the burden remains high, especially in low-income and middle-income countries. During the COVID-19 pandemic, with…
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
This first-in-human aerosol BCG controlled human infection model was sufficiently well tolerated. Further work will evaluate the utility of this model in assessing vaccine efficacy…
A new tool for accelerating tuberculosis vaccine development
Tuberculosis remains a formidable global health challenge, causing substantial morbidity and mortality due to the limited protection in the lungs provided by the current BCG…
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial
CTH522, adjuvanted with CAF01 or CAF09b, is safe and immunogenic, with 85 μg CTH522-CAF01 inducing robust serum IgG binding titres. Intradermal vaccination conferred systemic IgG…
Immunological responses in a Chlamydia trachomatis vaccine trial
A vaccine against chlamydia is widely agreed to be an essential public health control measure for both sexually transmitted and ocular infections.1 There have been…
Is there a need for an alternative varicella vaccine?
Varicella, also known as chickenpox, is an infectious disease with a characteristic skin rash caused by the Varicella zoster virus. After the initial infection, varicella…
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial
The three dose groups of the candidate v7D vaccine exhibit similar humoral immunogenicity to the vOka vaccine and are well tolerated. These findings encourage further…
Listeria monocytogenes: a rare, deadly cause of peritonitis
Invasive listeriosis is one of the most serious foodborne diseases, and can be categorised into three main clinical forms: septicaemic listeriosis, neurolisteriosis, and pregnancy-associated listeriosis.1…